September 11, 2020. Wednesday din te AstraZeneca laga CEO Pascal Soriot para besas te koishe ke, novel coronavirus kelaaf te pharmaceutical company para vaccine bonai thaka toh 2020 saal nohoile 2021 saal soruh samay paijabo koishe. Soriot para koishe ke, joti trail rokina thaka toh soruh hoile company khan para vaccine thiboli ready thakibo lage aro approval babo.
Etu hafta agae te UK-Swedish company para tai khan manuh ekta ke bemar howah beche ek paar nemite rokishe. Bemar toh spinal cord te infection kora ase koishe. Financial Times newspaper para khobor thishe ke, AstraZeneca laga COVID-19 vaccine clinical trials toh aha hafta para aro soruh koriboli koishe. “ami khan etu saal kotom samay nohoile aha saal soruh samay vaccine toh olabo,” koikena Soriot para Tortoise media group logot kowah, Guardian newspaper para janai thishe. CEO laga hesab te, trails thaka samay roka toh neem ase. Kotha toh kali ke ase koile toh Duniyaa khan para saa nai. Etu eneka hoilebi, ami khan kam koriase aro etu saal kotom nekora agae te data submit korikena approval babo”, tai aro koishe. AstraZeneca para Vaccine bonai thaka toh Oxford University’s Jenner Institute aro the Oxford Vaccine Group logot melikena phase 3 trials jaiase aro final stage hoikena safety aro efficacy data submit korikena health regulators laga hath para approval babo koishe. Duniyaa te, 50,000 manuh khan para clinical studies te part loiase aro candidate vaccine AZD1222 koikena , etu para COVID-19 ke immune response thiboli koishe.
Add Comment